[1]万 军.血清肿瘤标志物CA153,CA125,CEA和HER-2联合检测在乳腺癌诊断中的价值[J].现代检验医学杂志,2018,33(06):119-121.[doi:10.3969/j.issn.1671-7414.2018.06.031]
　WAN Jun.Value of Combined Detection of Tumor Markers CA153,CA125,CEA and HER-2 in the Diagnosis of Breast Cancer[J].Journal of Modern Laboratory Medicine,2018,33(06):119-121.[doi:10.3969/j.issn.1671-7414.2018.06.031]
点击复制

血清肿瘤标志物CA153,CA125,CEA和HER-2联合检测在乳腺癌诊断中的价值()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第33卷
期数:
2018年06期
页码:
119-121
栏目:
论著
出版日期:
2018-12-24

文章信息/Info

Title:
Value of Combined Detection of Tumor Markers CA153,CA125,CEA and HER-2 in the Diagnosis of Breast Cancer
文章编号:
1671-7414(2018)06-119-03
作者:
万 军
经济技术开发区(头屯河区)第一人民医院,乌鲁木齐 830023
Author(s):
WAN Jun
the First People's Hospital of Economic and Technological Development Zones(Tunhe District),Urumqi 830023,China
关键词:
肿瘤标志物;  糖链型153;  糖链型125;  癌胚抗原;  人类表皮生长因子受体-2;  乳腺癌
分类号:
R737.9; R730.43
DOI:
10.3969/j.issn.1671-7414.2018.06.031
文献标志码:
A
摘要:
目的 探究血清肿瘤标志物癌抗原153(CA153)、糖链型抗原125(CA125)、癌胚抗原(CEA)和人类表皮生长因子受体-2(HER-2)联合检测在乳腺癌诊断中的价值。方法 选取2017年1～12月期间收治的乳腺癌患者80例,同期乳腺良性疾病患者80例及同期健康体检者80例作为研究对象,分别作为乳腺癌组、乳腺良性疾病组及健康对照组,采用罗氏E411全自动化学发光免疫分析仪及配套试剂,定量检测全部入选研究对象的血清肿瘤标志物CA153,CA125,CEA和HER-2浓度,分析联合检测的意义。结果 乳腺癌组的CA153,CA125,CEA和HER-2水平均显著高于乳腺良性疾病组和对照组,差异均有统计学意义(F=6.541～9.854,均P<0.05); 乳腺良性疾病组的CA153,CA125,CEA和HER-2水平均高于对照组,差异均有统计学意义(F=4.953～7.924,P<0.05)。单纯检测CA153,CA125,CEA的敏感度对比,差异无统计学意义(χ2=0.564,P>0.05)。单纯检测CA153,CA125,HER-2的特异度对比,差异无统计学意义(χ2=0.405,P>0.05)。联合四者检测特异度及敏感度明显高于单项指标的特异度及敏感度,差异均有统计学意义(χ2=0.472～0.913,P<0.05)。结论 血清肿瘤标志物CA153,CA125,CEA和HER-2联合检测弥补了单一指标检测的不足,在乳腺癌诊断中敏感度高,值得临床推广。
Abstract:
Objective To explore the value of combined detection of serum tumor markers,such as carcinogen 153(CA153),carbohydrate chainantigen 125(CA125),carcinoembryonic antigen(CEA)and human epidermal growthfactor receptor-2(HER-2),in the diagnosis of breast cancer.Methods From January 2017 to December 2017,80 cases of breast cancer,80cases of benign breast disease and 80 cases of health check-up were selected as the subjects.They were divided into breast cancer group,benign breast disease group and healthy control group.Roche E411 automatic chemiluminescent immunoassay and related reagents were used to quantify the results.The concentrationsof serum tumor markers CA153,CA125,CEA and HER-2 were detected in all subjects,and the significance of combined detection was analyzed.ResultsThe levels of CA153,CA125,CEA and HER-2 in breast cancer group were significantly higher than those in the benign breast disease group and the control group,and the difference was statistically significant(t=6.541～9.854,all P<0.05).The levels of CA153,CA125,CEA and HER-2 in the benign breast disease group were higher than those in the control group,and the differences were of the significance(F=4.953～7.924,P<0.05).There was no significant difference in sensitivity between CA153,CA125 and CEA(χ2=0.564,P>0.05).Simple detection of CA153,CA125 and HER-2 specificity comparison,no significant difference(χ2=0.405,P>0.05).The specificity and sensitivity of combined four methods were significantly higher than that of single method(χ2=0.472～0.913,P<0.05).Conclusion The combined detection of tumor markers CA153,CA125,CEA and HER-2 has high sensitivity in the diagnosis of breast cancer,and is worth popularizing.

参考文献/References:

[1] 南永刚,许建林,李 楠,等.CA153,CA125联合HER-2检测在乳腺癌各临床分期诊断中的应用[J].现代肿瘤医学,2016,24(19):3070-3073.
Nan YG,Xu JL,Li N,et al.The role of CA153,CA125,HER-2 combined detection for the diagnosis of breast cancer[J].Modern Oncology,2016,24(19):3070-3073.
[2] 周逸琴,张 杰,郑玉平.CA153,CA199,CA125和FER在乳腺癌诊断中的价值[J].临床和实验医学杂志,2014,13(1):53-55.
Zhou YQ,Zhang J,Zheng YP.The significance of CA153,CA199,CA125and FER in diagnosis of breast cancer[J].Journal of Clinical and ExperimentalMedicine,2014,13(1):53-55.
[3] 詹红泉.CEA,CA153,CA125,CA199,CYFRA21-1联合检测乳腺癌的诊断价值[J].浙江临床医学,2016,18(3):555-556.
Zhan HQ.The diagnostic value of CEA,CA153,CA125,CA199,CYFRA21-1 combined detection of breast cancer[J].Zhejiang Clinical Medicine, 2016,18(3):555-556.
[4] 熊 娟.探讨肿瘤标志物(CA153,CA199,CA125,CA153)联合检测对乳腺癌、卵巢癌和结直肠癌的诊断价值[J].中国社区医师,2017,33(1):93-94.
Xiong J.Diagnostic value of tumor markers(CA153,CA199,CA125,CEA)combined detection in breast cancer,ovarian cancer and colorectal cancer[J].Chinese Community Journal,2017,33(1):93-94.
[5] 詹 颉,常宁宁,李小侠,等.CEA,AFP,CA125,CA199和CA72-4联合检测在鉴别卵巢良恶性疾病中的应用价值[J].现代检验医学杂志,2015,30(5):50-52.
Zhan J,Chang NN,Li XX,et al.Clinical velue of combined detectionof CEA,AFP,CA125,CA199 and CA72-4 in the identification of ovarian benign and malignant diseases[J].Journal of Modern Laboratory Medicine,2015,30(5):50-52.
[6] 沈 林.5种血清肿瘤标志物联合检测在乳腺癌诊断中的临床价值[J].国际检验医学杂志,2014,35(18):2531-2532.
Shen L.Clinical value of combined detection of five serum tumor markers in the diagnosis of breast cancer[J].International Journal of LaboratoryMedicine,2014,35(18):2531-2532.
[7] 张红雨,马兴璇.联合检测D-二聚体和CA153在乳腺癌诊治中的临床意义[J].现代检验医学杂志,2015,30(2):137-138.
Zhang HY,Ma XX.Clinical significance of combined detection of D-dimer and CA153 in the diagnosis and treatment of breast cancer[J].Journal ofModern Laboratory Medicine,2015,30(2):137-138.
[8] 洪 宏,袁建芬,喻海忠.血清miR-765和CA153联合检测对乳腺癌的诊断价值[J].现代检验医学杂志,2018,33(3):92-94.
Hong H,Yuan JF,Yu HZ.Diagnostic value of combined detection of serum miR-765 and CA153 in breast cancer[J].Journal of Modern Laboratory Medicine,2018,33(3):92-94.
[9] 高 华,李玉柱,韩龙才,等.Logistic回归和ROC工作曲线评价联合检测血清CA153,TPS,CYFRA21-1在乳腺癌诊断中的临床价值[J].现代检验医学杂志,2018,33(3):60-64.
Gao H,Li YZ,Han LC,et al.Clinical value of logistic regression and ROC work curve evaluating serum CA153,TPS and CYFRA21-1 for diagnosis of breast cancer[J].Journal of Modern Laboratory Medicine,2018,33(3):60-64.

相似文献/References:

[1]王红梅,陈晔洲,田晶晶,等.新型肿瘤标志物人PF4重组表达、活性鉴定及单克隆抗体制备[J].现代检验医学杂志,2015,30(05):12.[doi:10.3969/j.issn.1671-7414.2015.05.005]
　WANG Hong-mei,CHEN Ye-zhou,TIAN Jing-jing,et al.Recombination，Expression，Activity Identification and Monoclonal Antibody Preparation of the Human Platelet Factor 4 as a New Cancer Marker[J].Journal of Modern Laboratory Medicine,2015,30(06):12.[doi:10.3969/j.issn.1671-7414.2015.05.005]
[2]余安运,陶丹,刘夏炎,等.肿瘤标志物在消化系统肿瘤早期诊断中的应用[J].现代检验医学杂志,2015,30(06):133.[doi:10.3969/j.issn.1671-7414.2015.06.041]
　YU An-yun,TAO Dan,LIU Xia-yan,et al.Clinical Value of Blood Serums Tumor Marker in Early Diagnosis of Digestive System Neoplasms[J].Journal of Modern Laboratory Medicine,2015,30(06):133.[doi:10.3969/j.issn.1671-7414.2015.06.041]
[3]王 麟,周朝琼,徐晓华,等.血清肿瘤标志物的参考变化值和参考变化因子应用比较研究[J].现代检验医学杂志,2020,35(01):150.[doi:10.3969/j.issn.1671-7414.2020.01.040]
　WANG Lin,ZHOU Chao-qiong,XU Xiao-hua,et al.Comparative Study on the Reference Change Value and Reference Change Factor of Serum Tumor Markers[J].Journal of Modern Laboratory Medicine,2020,35(06):150.[doi:10.3969/j.issn.1671-7414.2020.01.040]
[4]张　磊a,李德涛a,朱　艳a,等.6 种化学发光系统检测肿瘤标志物的应用评估分析[J].现代检验医学杂志,2020,35(02):88.[doi:10.3969/j.issn.1671-7414.2020.02.025]
　ZHANG Leia,LI De-taoa,ZHU Yana,et al.Methodological Evaluation of Six Chemiluminescence DetectionSystems for Tumor Markers[J].Journal of Modern Laboratory Medicine,2020,35(06):88.[doi:10.3969/j.issn.1671-7414.2020.02.025]
[5]李　辉,汪春新,秦明明,等.肺癌患者血清7项肿瘤标志物联合检测在病理分型及临床分期中的应用价值研究[J].现代检验医学杂志,2021,36(04):5.[doi:10.3969/j.issn.1671-7414.2021.04.002]
　LI Hui,WANG Chun-xin,QIN Ming-ming,et al.Study on the Application Value of Combined Detection of 7 Tumor Markersin Serum of Patients with Lung Cancer in Pathological Classificationand Clinical Staging[J].Journal of Modern Laboratory Medicine,2021,36(06):5.[doi:10.3969/j.issn.1671-7414.2021.04.002]
[6]郝晓燕,周 磊,白丛霞,等.基于机器学习方法建立血清多种肿瘤标志物联合区分胃炎和胃癌的三种模型及评价[J].现代检验医学杂志,2023,38(02):124.[doi:10.3969/j.issn.1671-7414.2023.02.023 ]
　HAO Xiao-yan,ZHOU Lei,BAI Cong-xia,et al.Establishment and Evaluation of Three Models for the Distinguish Gastritis and Gastric Cancer with Multiple Serum Tumor Markers Based on Machine Learning Methods[J].Journal of Modern Laboratory Medicine,2023,38(06):124.[doi:10.3969/j.issn.1671-7414.2023.02.023 ]

备注/Memo

备注/Memo:
作者简介:万 军(1971-),男,本科,主管检验师,现从事临床检验工作,E-mail:782179631@qq.com。
更新日期/Last Update: 2018-11-30